Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
A10 Networks 3Q 2025 Earnings Call - AI Infrastructure Drives 12% Revenue Growth with Security-Led Solutions Surpassing 65%
A10 Networks reported a strong third quarter for 2025, with revenue up nearly 12% year-over-year to $74.7 million, powered by robust demand in AI infrastructure and security-led products. Growth was l...
- A10 Networks achieved nearly 12% year-over-year revenue growth in Q3 2025, totaling $74.7 million.
- North American enterprise customers and cloud service providers drove revenue growth, while macro headwinds affected other regions.
- Security-led solutions surpassed the long-term target of 65% of total revenue, driven by customer demand.
- +12 more takeaways
Tempus AI Q3 2025 Earnings Call - Positive Adjusted EBITDA and 33% Genomics Volume Growth Mark Milestone Quarter
Tempus AI reported a milestone third quarter in 2025, delivering 33% overall growth in genomics volumes led by oncology (27%) and hereditary testing (37%). The company achieved positive adjusted EBITD...
- Tempus posted 33% growth in genomics volume: oncology up 27%, hereditary up 37%, with hereditary growth expected to moderate to low- to mid-20s but still strong.
- Data licensing business grew 38% in Q3 with $150 million in new multi-year contract bookings, adding to a growing backlog north of $350 million.
- Tempus achieved positive adjusted EBITDA for the first time, a 10-year milestone, despite incremental expenses from the mid-quarter Paige acquisition.
- +9 more takeaways
Matson Q3 2025 Earnings Call - Navigating Tariff Uncertainty with Stable Domestic Growth and Strategic Pricing
Matson reported a challenging third quarter in 2025 marked by global trade volatility and tariff uncertainties, which led to lower operating income, particularly in the China ocean transportation segm...
- Q3 2025 operating income declined by $81.3 million year-over-year to $161 million, chiefly due to lower freight rates and volume in China.
- China service container volume dropped 12.8% year-over-year amid tariff uncertainty and global trade volatility.
- Domestic trade lanes showed resilience with Hawaii volume stable (+0.3%) and Alaska volume increasing 4.1%, while Guam volume declined 4.2%.
- +12 more takeaways
Digital Turbine Fiscal 2026 Q2 Earnings Call - Strong Growth Fueled by AI, International Expansion, and Brand Direct Engagement
Digital Turbine reported a robust Q2 fiscal 2026 with revenue rising 18% year-over-year to $140.4 million and Adjusted EBITDA surging 78%, underscoring scalable operating leverage. The On-Device Solut...
- Digital Turbine posted $140.4 million in Q2 revenue, an 18% year-over-year increase.
- Adjusted EBITDA rose 78% year-over-year to $27.2 million, showcasing operational leverage.
- On-Device Solutions segment grew 17% annually, generating $96 million in revenue.
- +12 more takeaways
Skyworks 4Q 2025 Earnings Call - Outperformance in Mobile and Broad Market Growth Drive Strong Results
Skyworks reported robust fourth quarter fiscal 2025 results with revenue hitting $1.1 billion and EPS surpassing expectations at $1.76. The company benefited from stronger-than-anticipated mobile unit...
- Skyworks delivered $1.1 billion revenue and $1.76 EPS in 4Q fiscal 2025, exceeding guidance and expectations.
- Mobile revenue surged 21% sequentially and 7% year-over-year, fueled by higher unit sales and improved product mix at largest customer.
- Strong momentum in Android smartphone segment and broad market growth driven by edge IoT, automotive, and data center infrastructure.
- +7 more takeaways
LifeVantage Q1 Fiscal 2026 Earnings Call - Strategic Acquisition of LoveBiome Poised to Drive Future Growth
LifeVantage reported a modest 0.7% revenue increase to $47.6 million for Q1 fiscal 2026, with adjusted EBITDA dipping to $3.9 million amid margin pressures and incentive costs. The quarter was marked ...
- LifeVantage’s Q1 fiscal 2026 net revenue was $47.6 million, up 0.7% year-over-year, reflecting modest growth in Americas and Asia-Pacific/Europe regions.
- Adjusted EBITDA decreased by $500,000 to $3.9 million, primarily due to lower gross margins and higher commissions, partially offset by reduced SG&A expenses.
- On October 1st, LifeVantage closed the acquisition of LoveBiome, gaining entry into the rapidly expanding $14B gut microbiome health market projected to grow to $32.4B by 2035.
- +8 more takeaways
Cumberland Pharmaceuticals Q3 2025 Earnings Call - Strategic Expansion with Talicia Joint Venture and Clinical Progress on Ifetroban
Cumberland Pharmaceuticals marked Q3 2025 with promising operational and financial developments, notably entering a joint commercialization venture with RedHill Biopharma for Talicia, an FDA-approved ...
- Cumberland entered a joint commercialization agreement with RedHill Biopharma to co-own and market Talicia, an FDA-approved multi-drug capsule for H. pylori infections, with protected patent rights through 2042 and 8 years of market exclusivity.
- Talicia sales totaled $8 million in 2024, and Cumberland will invest $4 million over two years, leveraging its existing sales force and sharing net revenues equally with RedHill.
- Vibativ, the intravenous antibiotic for resistant gram-positive infections, expanded availability via new national purchasing agreements with Vizient and Premier Inc., enhancing U.S. hospital access.
- +9 more takeaways
Mirum Pharmaceuticals Q3 2025 Earnings Call - Solid Revenue Growth and Pivotal Volixibat Readout on Horizon
Mirum Pharmaceuticals posted a robust Q3 2025 with $133 million in revenue, a 47% increase year-over-year, powered by strong sales of LIVMARLI in both US and international markets and gains in their b...
- Q3 revenue reached $133 million, a near 50% rise from last year, driven by LIVMARLI and bioacquired product sales.
- LIVMARLI sales totaled $92 million, with strong US demand in Alagille syndrome and PFIC and growing international uptake, including a first full quarter of partner Takeda's Japan launch.
- Mirum expects to exceed its 2025 revenue guidance range of $500-$510 million, supported by strong US business and bioacquired portfolio stability.
- +11 more takeaways
RideNow Group Q3 2025 Earnings Call - Operational Turnaround Drives Record Adjusted EBITDA Despite Revenue Pressures
RideNow Group reported a marked operational turnaround in Q3 2025, delivering $12.3 million in Adjusted EBITDA, an 80% increase year-over-year, even as revenue declined 4.7% due to the vehicle transpo...
- RideNow achieved $12.3 million Adjusted EBITDA in Q3 2025, up $5.5 million (80%) from prior year despite a 4.7% revenue decline.
- Revenue drop was driven solely by a steep decrease in the vehicle transportation segment, Wholesale Express, which fell from $15.1 million to $1 million revenue.
- Core powersports segment posted first year-over-year improvement in revenue, unit sales (new and pre-owned), and gross profit since Q2 2023.
- +7 more takeaways
AudioEye Q3 2025 Earnings Call - Record Revenue and EBITDA on Strong EU and Enterprise Channel Momentum
AudioEye delivered its 39th consecutive quarter of record revenue with $10.2 million in Q3 2025, marking a 15% year-over-year increase and a $2.5 million adjusted EBITDA — a company record with a 24% ...
- AudioEye achieved record Q3 2025 revenue of $10.2 million, its 39th straight quarter of record revenue, up 15% year-over-year.
- Adjusted EBITDA hit a record $2.5 million with a 24% margin, up from $1.9 million in Q2 2025.
- Significant growth in the enterprise channel (+26% YoY) and partner/marketplace channel (+7% YoY) contributed to strong recurring revenue expansion.
- +12 more takeaways